CM-101 in PSC Patients -The SPRING Study

NCT04595825 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Sclerosing Cholangitis

Interventions

BIOLOGICAL: Anti-human CCL24 monoclonal antibody (CM-101)
OTHER: Placebo

Sponsor

ChemomAb Ltd.